Tissue-resident Memory T Cells Expression Among the Repigmentation Patterns Induced by NB-UVB Phototherapy in Vitiligo
NCT05506995 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11
Last updated 2022-08-18
Summary
Vitiligo is the most commonly acquired depigmentation disorder characterized by selective destruction of melanocytes resulting in well-circumscribed achromic macules. Tissue-resident memory T cells (TRM) are memory T lymphocyte subsets that reside in the skin, lack recirculation, proliferate locally, produce cytokines, and may be implicated in relapses. NB-UVB Phototherapy induces repigmentation in certain patterns. The aim of this study was to determine the levels of TRM cells on vitiligo lesions, and after phototherapy by repigmentation pattern.
Conditions
- Vitiligo
Sponsors & Collaborators
-
Universidad Autonoma de San Luis Potosí
lead OTHER
Principal Investigators
-
Juan P Castanedo-Cazares, MD · Universidad Autonoma de San Luis Potosi
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-08-01
- Primary Completion
- 2022-07-24
- Completion
- 2022-08-03
Countries
- Mexico
Study Locations
More Related Trials
-
Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo
NCT01511965 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions
NCT05927272 ·Status: RECRUITING ·Phase: NA
-
Epidermal Cell Transplantation in Vitiligo Skin
NCT01629979 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Patients With Non-segmentary Vitiligo
NCT03249064 ·Status: COMPLETED
-
Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo
NCT05121532 ·Status: UNKNOWN ·Phase: NA
-
Photoprotection Habits in Patients With Vitiligo
NCT03323125 ·Status: COMPLETED
-
Vitiligo Treatment by Targeting TYK2 Mediated Responses
NCT06327321 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity
NCT03741738 ·Status: COMPLETED
-
The Mechanism of Melanocyte Self-Assembly on Biomaterials and the Functional Analysis
NCT00509314 ·Status: UNKNOWN
-
Gasdermin D Expression in Generalized Vitiligo Patients After Narrow-band Ultraviolet B Therapy
NCT06546059 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Trem-1 and Ultraviolet Radiation-induced Immune Suppression
NCT05020496 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Stress Response Pathways in Vitiligo
NCT02797574 ·Status: COMPLETED ·Phase: NA
-
IL35 Level in Vitiligo
NCT05980390 ·Status: UNKNOWN
-
A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo
NCT05053022 ·Status: COMPLETED ·Phase: NA
-
Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungoides
NCT05526638 ·Status: UNKNOWN ·Phase: NA
-
Building an Assessment Model for Vitiligo Activity and Prognosis Using Peripheral Blood Cytokine Profiles
NCT07298551 ·Status: NOT_YET_RECRUITING
-
Histochemical Study of Vitiligo in Sohag University Hospital Patients
NCT05869942 ·Status: UNKNOWN ·Phase: NA
-
Vitiligo, New Treatment and Serum s100B
NCT06768840 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
NCT00368784 ·Status: COMPLETED
-
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
NCT00946699 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Serum and Tissue Cathepsin L in Non-segmental Vitiligo Patients
NCT06261073 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Patient Reported Outcomes With UVA-1 Therapy for Treatment of Sclerosing Skin Diseases
NCT04922736 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Human Melanocytes After the Use of PRP Versus Fractional CO2 Laser in Vitiligo
NCT04320160 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Serological Markers of Vitiligo Activity
NCT06731283 ·Status: ACTIVE_NOT_RECRUITING
-
A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo
NCT06319781 ·Status: RECRUITING